Emerging infectious threats to the blood supply

Annual Review of Medicine

Volumn 55, Issue , 2004, Pages 191-207

  Dodd, Roger Y ^a   Leiby, David A ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Blood safety; Disease; Interventions; Transfusion; Transmission

Indexed keywords

ANAPLASMA PHAGOCYTOPHILUM; BABESIA; BACTERIAL INFECTION; BIOSAFETY; BLOOD TRANSFUSION; BORRELIA BURGDORFERI; EHRLICHIA CHAFFEENSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION PREVENTION; NONHUMAN; PLASMODIUM; POPULATION RESEARCH; PRION DISEASE; PRIORITY JOURNAL; PROTOZOAL INFECTION; RECIPIENT; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; THREAT; TRYPANOSOMA CRUZI; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; COMMUNICABLE DISEASES, EMERGING; HUMANS;

EID: 1542269157     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.55.091902.103831     Document Type: Review

References (81)

1. Dodd RY, Notari EP, Stramer SL. 2002. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42:975-79
2. Kleinman S. 2001. Transfusion safety when you don't know what you are looking for: issues related to emerging pathogens. In Blood Safety in the New Millennium, ed. SL Stramer, pp. 79-96. Bethesda, MD: Am. Assoc. Blood Banks
3. Blajchman MA, Bull SB, Feinman SV. 1995. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Lancet 345:21-25
4. Nash D, Mostashari F, Fine A, et al. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:1807-14
5. Petersen LR, Marfin AA. 2002. West Nile virus: a primer for the clinician. Ann. Intern. Med. 137:173-79
6. Biggerstaff BJ, Petersen LR. 2002. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 42:1019-26
7. Pealer LN, Marfin AA, Petersen LR, et al. 2003. Transmission of West Nile virus through blood transfusion - United States, 2002. N. Engl. J. Med. In press
8. US Food and Drug Administration. 2003. Guidance for industry, revised recommendations for the assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile virus infection, http://www.fda.gov/cber/ gdlns/wnvguid.pdf
9. Donnelly CA, Ghani AC, Leung GM, et al. 2003. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361:1761-6
10. Marra MM, Jones SJM, Astell CR. 2003. The genome sequence of the SARS-associated coronavirus. Science 300:1399-404
11. Rota PA, Oberste MA, Monroe SS, et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-99
12. Leroy EM, Baize S, Volchkov VE, et al. 2000. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355:2210-15
13. Duchin JS, Koster FT, Peters CJ, et al. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330:949-55
14. Blackbourn DJ, Ambroziak J, Lennette E, et al. 1997. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 349:609-11
15. Farge D, Lebbé C, Marjanovic Z, et al. 1999. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Transplantation 67: 1236-42
16. Milliancourt C, Barete S, Marcelin AG, et al. 2001. Human herpesvirus-8 seroconversions after renal transplantation. Transplantation 72:1319-20
17. Regamey N, Tamm M, Wernli M, et al. 1998. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N. Engl. J. Med. 339:1358-63
18. Cannon MJ, Dollard SC, Smith DK, et al. 2001. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N. Engl. J. Med 344:637-43
19. Challine D, Roudot-Thoraval F, Sarah T, et al. 2001. Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 41:1120-5
20. Operskalski EA, Busch MP, Mosley JW, et al. 1997. Blood donations and viruses. Lancet 349:1327
21. Anderson BE, Dawson JE, Jones DC, Wilson KH. 1991. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J. Clin. Microbiol 29:2838-42
22. Dumler JS, Bakken JS. 1995. Ehrlichial diseases of humans: emerging tick-borne infections. Clin. Infect. Dis. 20:1102-10
23. Heo EJ, Park JH, Koo JR, et al. 2002. Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. J. Clin. Microbiol. 40:3082-85
24. Keysary A, Amram L, Keren G, et al. 1999. Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg. Infect. Dis. 5:775-78
25. Centers for Disease Control and Prevention. 2002. Summary of notifiable diseases - United States, 2000. Morbid. Mortal. Wkly. Rep. 49:x-xi
26. McKechnie DB, Slater KS, Childs JE, et al. 2000. Survival of Ehrlichia chaffeensis in refrigerated, ADSOL-treated RBCs. Transfusion 40:1041-47
27. Bakken JS, Dumler JS. 2000. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31:554-60
28. Fritz CL, Kjemtrup AM, Conrad PA, et al. 1997. Seroepidemiology of emerging tickborne infectious diseases in a Northern California community. J. Infect. Dis. 175:1432-39
29. Hilton E, DeVoti J, Benach JL, et al. 1999. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am. J. Med. 106:404-9
30. Bakken JS, Goellner P, Van Etten M, et al. 1998. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin. Infect. Dis. 27:1491-96
31. Leiby DA, Chung APS, Cable RG, et al. 2002. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion 42:1585-91
32. Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, et al. 2002. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J. Clin. Microbiol. 40:2612-15
33. Kalantarpour F, Chowdhury I, Wormser GP, et al. 2000. Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin. Microbiol. 38:2398-99
34. Eastlund T, Persing D, Mathiesen D, et al. 1999. Human granulocytic ehrlichiosis after red cell transfusion. Transfusion 39(Suppl.):117S (Abstr.)
35. Burgdorfer W, Barbour AG, Hayes SF, et al. 1982. Lyme disease - a tick-borne spirochetosis? Science 216:1317-19
36. Steere AC, Grodzicki RL, Kornblatt AN, et al. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733-40
37. Cable R, Krause P, Badon S, et al. 1993. Acute blood donor co-infection with Babesia microti (Bm) and Borrelia burgdorferi (Bb). Transfusion 33(Suppl.):50S (Abstr.)
38. Badon SJ, Fister RD, Cable RG. 1989. Survival of Borrelia burgdorferi in blood products. Transfusion 29:581-83
39. Cable RG, Trouern-Trend J. 2001. Tick-borne infections. In Blood Safety and Surveillance, ed. JV Linden, C Bianco, pp. 399-422. New York: Marcel Dekker
40. Shrestha M, Grodzicki RL, Steere AC. 1985. Diagnosing early Lyme disease. Am. J. Med. 78:235-40
41. World Health Organization. 1997. World malaria situation in 1994. Wkly. Epidemiol. Rec. 72:269-76
42. Phillips P, Nantel S, Benny WB. 1990. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review. Rev. Infect. Dis. 12:1100-8
43. Mungai M, Tegtmeier G, Chamberland M, et al. 2001. Transfusion- transmitted malaria in the United States from 1963 through 1999. N. Engl. J. Med. 344:1973-78
44. Slinger R, Giulivi A, Bodie-Collins M, et al. 2001. Transfusion- transmitted malaria in Canada. Can. Med. Assoc. J. 164:377-79
45. Thang HD, Elsas RM, Veenstra J. 2002. Airport malaria: report of a case and a brief review of the literature. Neth. J. Med. 60:441-43
46. Centers for Disease Control and Prevention. 2002. Local transmission of Plasmodium vivax malaria - Virginia, 2002. Morbid. Mortal. Wkly. Rep. 51:921-23
47. Kjemtrup AM, Conrad PA. 2000. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol. 30:1323-37
48. McQuiston JH, Childs JE, Chamberland ME, et al. 2000. Transmission of tick-borne agents by blood transfusion: a review of known and potential risks in the United States. Transfusion 40:274-84
49. Homer MJ, Aguilar-Delfin I, Telfored SR, et al. 2000. Babesiosis. Clin. Microbiol. Rev. 13:451-69
50. Piesman J, Spielman A. 1982. Babesia microti: infectivity of parasites from ticks for hamsters and white-footed mice. Exp. Parasitol. 53:242-48
51. Quick RE, Herwaldt BL, Thromford JW, et al. 1993. Babesiosis in Washington State: a new species of Babesia? Ann. Intern. Med. 119:284-90
52. Gorenflot A, Moubri K, Precigout E, et al. 1998. Human babesiosis. Ann. Trop. Med. Parasitol. 92:489-501
53. Persing DH, Herwaldt BL, Glaser C, et al. 1995. Infection with a Babesia-like organism in northern California. N. Engl. J. Med. 332:298-303
54. Herwaldt BL, Persing DH, Précigout EA, et al. 1996. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann. Intern. Med. 124:643-50
55. Beattie JF, Michelson ML, Holman PJ. 2002. Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N. Engl. J. Med. 347:697-98
56. Matsui T, Inoue R, Kajimoto K, et al. 2000. First documentation of transfusion-associated babesiosis in Japan. Rinsho Ketsueki 41:628-34 (Japanese with English summary)
57. Lux JZ, Weiss D, Linden JV, et al. 2003. Transfusion-associated babesiosis after heart transplant. Emerg. Infect. Dis. 9:116-19
58. Jassoum BS, Fong IW, Hannach B, et al. 2000. Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. Can. Commun. Dis. Rep. 26:9-13
59. Kjemtrup AM, Lee B, Fritz CL, et al. 2002. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 42:1482-87
60. Mintz ED, Anderson JF, Cable RG, et al. 1991. Transfusion-transmitted babesiosis: a case report from a new endemic area, Transfusion 31:365-68
61. Cable RG, Badon S, Trouern-Trend, et al. 2001. Evidence for transmission of Babesia microti from Connecticut blood donors to recipients. Transfusion 41(Suppl.):12S-13S (Abstr.)
62. Leiby DA, Chung APS, Cable RG, et al. 2002. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion 42:1585-91
63. Houghton RL, Homer MJ, Reynolds LD, et al. 2002. Identification of Babesia microti-specific immunodominant epitopes and development of a peptide EIA for detection of antibodies in serum. Transfusion 42:1488-96
64. Persing DH, Mathiesen D, Marshall WF, et al. 1992. Detection of Babesia microti by polymerase chain reaction. J. Clin. Microbiol. 30:2097-103
65. 2000. Chagas disease, Chile. Certification of interruption of transmission. Wkly. Epidemiol. Rec. 75:10-12
66. Kirchhoff LV. 1999. American trypanosomiasis (Chagas' disease). In Tropical Infectious Diseases: Principles, Pathogens, and Practice, ed. RL Guerrant, DH Walker, PF Weller, pp. 785-96. New York: Churchill Livingstone
67. Kirchhoff LV, Gam AA, Gilliam FC. 1987. American trypanosomiasis (Chagas' disease) in Central American immigrants. Am. J. Med. 82:915-20
68. Leiby DA, Fucci MH, Stumpf RJ. 1999. Trypanosoma cruzi in a low-to moderate-risk blood donor population: seroprevalence and possible congenital transmission. Transfusion 39:310-15
69. Leiby DA, Lenes BA, Tibbals MA, et al. 1999. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N. Engl. J. Med. 341:1237-39
70. Cimo PL, Luper WE, Scouros MA. 1993. Transfusion-associated Chagas' disease in Texas: report of a case. Texas Med. J. 89:48-50
71. Grant IH, Gold JW, Wittner M, et al. 1989. Transfusion-associated acute Chagas disease acquired in the United States. Ann. Intern. Med. 111:849-51
72. Nickerson P, Orr P, Schroeder M-L, et al. 1989. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann. Intern. Med. 111:851-53
73. Lane DJ, Sher G, Ward B, et al. 2000. Investigation of the second case of transfusion transmitted Chagas disease in Canada. Blood 96:60a (pt. 1)
74. Leiby DA, Herron RM, Read EJ, et al. 2002. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42:549-55
75. Blood Products Advisory Committee. 2002. Transcripts of the September 12, 2002 Blood Products Advisory Committee Meeting, CBER, FDA. http://www. fda.gov/OHRMS/DOCKETS/ac/02/trans cripts/3892t1-03.pdf
76. Leiby DA, Read EJ, Lenes BA, et al. 1997. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in U.S. blood donors. J. Infect. Dis. 176:1047-52
77. Prusiner SB. 2001. Shattuck Lecture - neurodegenerative diseases and prions. N. Engl. J. Med. 344:1516-26
78. Collinge J. 1999. Variant Creutzfeldt-Jakob disease. Lancet 354:317-23
79. Brown P, Cervenakova L, McShane LM, et al. 1999. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeld-Jakob disease in humans. Transfusion 39: 1169-78
80. Houston F, Foster JD, Chong A, et al. 2000. Transmission of BSE by blood transfusion in sheep. Lancet 356:999-1000
81. Hunter N, Foster J, Chong A, et al. 2002. Transmission of prion diseases by blood transfusion. J. Gen. Virol. 83:2897-905